Digital pharma upstarts face down threats, legacy rivals
February 2, 2021
A growing crop of venture-backed online-only pharmacy startups like NowRx, Ro and Medly are trying to crack the $300 billion-plus prescription drug industry. In a new research note, PitchBook analysts outline the risks and potential rewards awaiting these challengers, including:
- Online fraud is a looming threat that digital companies must tackle
- Central distribution hubs, walk-in patient services and aid for the uninsured are among the experiments in the fragmented e-pharmacy industry
- Consolidation outlook: Pharmacy incumbents are likely to acquire startups in this market